» Articles » PMID: 36840501

Limonin Ameliorates Indomethacin-induced Intestinal Damage and Ulcers Through Nrf2/ARE Pathway

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause intestinal damage and ulcers and the incidence is increasing. Limonin plays an important role in the regulation of inflammatory diseases, but it has not been reported in the treatment of intestinal injury and ulcers.

Methods: Indomethacin (INDO) induced intestinal injury and ulcer model in rats. The indexes related to intestinal injury were detected. Western blot and molecular docking techniques were used to detect the docking between Limonin and Nrf2. Next, ML385, an inhibitor of Nrf2/ARE signaling pathway, was applied to treat intestinal epithelial IEC-6 cells induced by INDO. And CCK8, Western blot, TUNEL, ELISA, DCFH-DA assay, kits, and immunofluorescence were conducted to detect cell activity, apoptosis, inflammatory response, oxidative stress, and tight junction again.

Results: INDO can significantly induce intestinal ulcerative lesions in rats. Limonin could improve intestinal ulcerative lesions induced by INDO in rats. Limonin could reduce INDO-induced inflammatory response and oxidative stress in the small intestine of rats, and improve the intestinal barrier dysfunction induced by INDO. Limonin could dock with Nrf2 structure and activate Nrf2/ARE signaling pathway. ML385 could reverse the protective effect of Limonin against INDO-induced cell damage.

Conclusion: Limonin ameliorates INDO-induced intestinal damage and ulcers through Nrf2/ARE pathway.

Citing Articles

Enteric-Coated Aspirin Induces Small Intestinal Injury via the Nrf2/Gpx4 Pathway: A Promising Model for Chronic Enteropathy.

Zhang M, Xia S, Feng L, Han X, Zhang Y, Huang Y Drug Des Devel Ther. 2025; 19:891-910.

PMID: 39959119 PMC: 11829608. DOI: 10.2147/DDDT.S493049.


The mechanism of enterogenous toxin methylmalonic acid aggravating calcium-phosphorus metabolic disorder in uremic rats by regulating the Wnt/β-catenin pathway.

Fan X, Li J, Gao Y, Li L, Zhang H, Bi Z Mol Med. 2025; 31(1):19.

PMID: 39844078 PMC: 11756144. DOI: 10.1186/s10020-025-01067-y.


Oral Ingestion of Yuzu Seed Oil Suppresses the Development of Atopic Dermatitis-like Skin Lesions in NC/Nga Mice.

Asano K, Watanabe Y, Miyamoto M, Toutani M, Mizobuchi S Int J Mol Sci. 2024; 25(5).

PMID: 38473936 PMC: 10932159. DOI: 10.3390/ijms25052689.


Toxicity evaluation of processing Evodiae fructus based on intestinal microbiota.

Liang X, Liu J, Di J, Xiao N, Peng Y, Tian Q Front Microbiol. 2024; 15:1336777.

PMID: 38435687 PMC: 10904473. DOI: 10.3389/fmicb.2024.1336777.


Limonin ameliorates indomethacin-induced intestinal damage and ulcers through Nrf2/ARE pathway.

Jia B, Zhao L, Liu P, Li M, Tian Z Immun Inflamm Dis. 2023; 11(2):e787.

PMID: 36840501 PMC: 9958512. DOI: 10.1002/iid3.787.

References
1.
Jin S, Wang J, Chen S, Jiang A, Jiang M, Su Y . A novel limonin derivate modulates inflammatory response by suppressing the TLR4/NF-κB signalling pathway. Biomed Pharmacother. 2018; 100:501-508. DOI: 10.1016/j.biopha.2018.02.046. View

2.
Beiranvand M, Bahramikia S, Dezfoulian O . Evaluation of antioxidant and anti-ulcerogenic effects of Eremurus persicus (Jaub & Spach) Boiss leaf hydroalcoholic extract on ethanol-induced gastric ulcer in rats. Inflammopharmacology. 2021; 29(5):1503-1518. DOI: 10.1007/s10787-021-00868-x. View

3.
Cheng Y, Wu C, Ho C, Yen G . Catechin protects against ketoprofen-induced oxidative damage of the gastric mucosa by up-regulating Nrf2 in vitro and in vivo. J Nutr Biochem. 2012; 24(2):475-83. DOI: 10.1016/j.jnutbio.2012.01.010. View

4.
Mahmoud M, Gamal S, El-Fayoumi H . Limonin attenuates hepatocellular injury following liver ischemia and reperfusion in rats via toll-like receptor dependent pathway. Eur J Pharmacol. 2014; 740:676-82. DOI: 10.1016/j.ejphar.2014.06.010. View

5.
Jia B, Zhao L, Liu P, Li M, Tian Z . Limonin ameliorates indomethacin-induced intestinal damage and ulcers through Nrf2/ARE pathway. Immun Inflamm Dis. 2023; 11(2):e787. PMC: 9958512. DOI: 10.1002/iid3.787. View